Stay updated on Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial

Sign up to get notified when there's something new on the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, with 25 locations now included and the option to show fewer collaborators.
    Difference
    0.5%
    Check dated 2024-07-23T15:36:35.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T09:16:35.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T15:48:06.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the version of the content on the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T11:52:22.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value 'Active, not recruiting' has been updated to 'Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS (TUDCA-ALS)' in the ClinicalTrials.gov study record NCT03800524.
    Difference
    100%
    Check dated 2024-06-26T10:27:21.000Z thumbnail image
  10. Check
    51 days ago
    Change Detected
    Summary
    The value 'Amyotrophic Primary' has recently changed to 'Primary Amyotrophic' on the webpage. This change likely reflects an update in medical and healthcare-related publications or documentation concerning Amyotrophic Lateral Sclerosis (ALS) treatment.
    Difference
    0.2%
    Check dated 2024-06-06T15:39:47.000Z thumbnail image

Stay in the know with updates to Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page.